Technical Analysis for AMPH - Amphastar Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 18.98 -0.26% -0.05
AMPH closed down 0.26 percent on Wednesday, December 4, 2019, on 1.23 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Up
See historical AMPH trend table...

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Stochastic Sell Signal Bearish 0.00%
Overbought Stochastic Strength 0.00%
Down 3 Days in a Row Weakness 0.00%
Volume Surge Other -0.26%
Weak + Overbought Other -0.26%
Overbought Stochastic Strength -0.26%
Fell Below 50 DMA Bearish -0.32%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -0.32%
Stochastic Reached Overbought Strength -0.32%

Older signals for AMPH ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Amphastar Pharmaceuticals, Inc., a generic and specialty pharmaceutical company, engages in the discovery, development, manufacture, and marketing of generic and proprietary pharmaceuticals, delivery systems, and active pharmaceutical ingredients. The company focuses on injectable, inhalation, and other categories of pharmaceutical products. Its products include Enoxaparin Sodium Injection, which is indicated for the prophylaxis of deep vein thrombosis, which may lead to pulmonary embolism and the inpatient/outpatient treatment of acute deep vein thrombosis; Amphadase, a protein enzyme that is prepared from a highly purified bovine testicular hyaluronidase; Cortrosyn for Injection, a diagnostic agent that is used in the screening of patients presumed to have adrenocortocal insufficiency; and prefilled disposable emergency syringes for crash cart use. The company's products also include Lidocaine HCl Jelly, a preservative-free topical local anesthetic agent that is provided in a prefilled syringe; Naloxone HCl Injection for the complete or partial reversal of narcotic depression and diagnosis of suspected acute opioid overdose; and Phytonadione Injection (Vitamin K1) for newborns. In addition, it markets its drug development pipeline and patented technologies. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California with manufacturing subsidiaries/facilities in South El Monte, California; and West Roxbury and Canton, Massachusetts.
Medicine Chemistry Pharmaceutical Pharmaceutical Products Pharmacology Medical Equipment Drug Development Active Pharmaceutical Ingredients Syringe Drug Paraphernalia Deep Vein Thrombosis Injection Heroin Hyaluronidase Lidocaine

Is AMPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Indicators
Indicator Value
52 Week High 25.43
52 Week Low 16.71
Average Volume 210,561
200-Day Moving Average 20.6838
50-Day Moving Average 19.2082
20-Day Moving Average 18.2635
10-Day Moving Average 18.633
Average True Range 0.6046
ADX 24.68
+DI 25.4746
-DI 19.2427
Chandelier Exit (Long, 3 ATRs ) 17.9262
Chandelier Exit (Short, 3 ATRs ) 18.5238
Upper Bollinger Band 19.711
Lower Bollinger Band 16.816
Percent B (%b) 0.75
BandWidth 15.851288
MACD Line -0.0712
MACD Signal Line -0.2778
MACD Histogram 0.2065
Fundamentals Value
Market Cap 876.78 Million
Num Shares 46.2 Million
EPS 0.08
Price-to-Earnings (P/E) Ratio 237.25
Price-to-Sales 3.41
Price-to-Book 2.55
PEG Ratio 2.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.79
Resistance 3 (R3) 19.80 19.55 19.66
Resistance 2 (R2) 19.55 19.34 19.54 19.61
Resistance 1 (R1) 19.26 19.21 19.14 19.25 19.56
Pivot Point 19.01 19.01 18.94 19.00 19.01
Support 1 (S1) 18.72 18.80 18.60 18.71 18.40
Support 2 (S2) 18.47 18.67 18.46 18.35
Support 3 (S3) 18.18 18.47 18.31
Support 4 (S4) 18.17